The Transcend VTLX-1 UHPLC System Introduced by Thermo Fisher ScientificÂ
Thermo Fisher Scientific's Transcend VLTX-1 UHPLC system automates LC-MS sample cleanup and preparation, enhancing throughput and efficiency.
Thermo Fisher Scientific's Transcend VLTX-1 UHPLC system automates LC-MS sample cleanup and preparation, enhancing throughput and efficiency.
Researchers have developed a new, less invasive blood collection device inspired by leeches, featuring a suction cup and microneedles.
The inFoods IBS test has been validated for use with finger stick blood samples simplifying collection and facilitating access to the test.
Babson Diagnostics and BD announced the expansion of a strategic partnership to move blood sample collection into new care settings.
Read MoreDried blood spot testing provides clinical labs an easy-to-collect, reliable, and cost-effective means to test for a variety of diseases.
Read MoreAkoya Biosciences has announced the commercial availability of the PhenoCycler-Fusion system for high-speed imaging of whole slides.
Read MoreResearch points to saliva testing as a potential alternative to blood sampling for patients with bipolar disorder, schizophrenia, and depression.
Read MoreTimely toxicology testing remains vital to patient treatment, but the challenge is staying ahead of emerging illicit drugs.
Read MoreAn update to the NSC-ADID recommendations for toxicology testing in impaired driving and motor vehicle fatalities has just been released.
Read MoreTo improve the development of new saliva-based diagnostic tests, the NIDCR has supported the development of the Human Salivary Proteome Wiki.
Read MoreThe CDC has updated its Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for COVID-19 with language clarifications.
Read MoreThe self-contained saliva collection kit provides sample consistency while suspending and neutralizing viral RNA transcripts, completely inactivating the live covid-19 virus.
Read MoreAnalysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read MoreThe AUR87A trial will involve 16 hospitals across Europe and the United States, making it the largest-ever prospective multicenter study of a diagnostic for the detection of recurrence after surgery in clear cell renal cell carcinoma.
Read MoreThe collaboration intends to create a kitted next-generation sequencing product that will enable researchers and biopharma companies to conduct biomarker discovery, using noninvasive blood samples collected from patients in clinical trials.
Read MoreThe Pulmonary Fibrosis Foundation advises that surgical lung biopsy be considered only for patients who lack a confident clinical-radiographic diagnosis after the appropriate noninvasive evaluation.
Read MoreThe Medicare LCD provides coverage for the Decipher prostate biopsy genomic test for men with both favorable and unfavorable intermediate-risk prostate cancer.
Read MoreNona Scientific’s Synthetic Urine Detection test detects both synthetic and adulterated urine, including 18 classes of subversion and adulteration.
Read More